842 reports of this reaction
1.2% of all DOXYCLYCLINE HYCLATE reports
#20 most reported adverse reaction
SINUSITIS is the #20 most commonly reported adverse reaction for DOXYCLYCLINE HYCLATE, manufactured by Lupin Pharmaceuticals, Inc.. There are 842 FDA adverse event reports linking DOXYCLYCLINE HYCLATE to SINUSITIS. This represents approximately 1.2% of all 70,851 adverse event reports for this drug.
Patients taking DOXYCLYCLINE HYCLATE who experience sinusitis should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
SINUSITIS is a less commonly reported adverse event for DOXYCLYCLINE HYCLATE, but still significant enough to appear in the safety profile.
In addition to sinusitis, the following adverse reactions have been reported for DOXYCLYCLINE HYCLATE:
The following drugs have also been linked to sinusitis in FDA adverse event reports:
SINUSITIS has been reported as an adverse event in 842 FDA reports for DOXYCLYCLINE HYCLATE. This does not prove causation, but indicates an association observed in post-market surveillance data.
SINUSITIS accounts for approximately 1.2% of all adverse event reports for DOXYCLYCLINE HYCLATE, making it a notable side effect.
If you experience sinusitis while taking DOXYCLYCLINE HYCLATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.